GlaxoSmithKline seeking to validate EU-GMP standards
May 14, 2020 | 08:00
Multinational corporations are rushing to seek official quality standards recognition in order to gain advantages and high profit in tenders of high-cost branded drugs in the lucrative Vietnamese market, but the journey will not be a fruitful one for all.
Mobile Version